ホーム>>PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt)

PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) (Synonyms: DOPI3,5P2, Phosphatidylinositol3,5bisphosphate C8)

カタログ番号GC44756

リン酸イノシトール(PtdIns)リン酸脂質は、全体の膜リン脂質のわずかな割合を占めています。

Products are for research use only. Not for human use. We do not sell to patients.

PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) 化学構造

サイズ 価格 在庫数 個数
100μg
$69.00
在庫あり
500μg
$308.00
在庫あり
1mg
$548.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. PtdIns-(3,5)-P2 (1,2-dioctanoyl) is a synthetic analog of natural phosphatidylinositol (PtdIns) featuring C8:0 fatty acids at the sn-1 and sn-2 positions. The compound features the same inositol and diacylglycerol (DAG) stereochemistry as the natural compound. PtdIns are phosphorylated to mono- (PtdIns-P; PIP), di- (PtdIns-P2; PIP2), and triphosphates (PtdIns-P3; PIP3). Hydrolysis of PtdIns-(4,5)-P2 by phosphoinositide (PI)-specific phospholipase C generates inositol triphosphate (IP3) and DAG which are key second messengers in an intricate biochemical signal transduction cascade. PtdIns-(3,4)-P2 is resistant to hydrolysis by phospholipase C.

レビュー

Review for PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.